These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34773352)

  • 1. Evaluating the prognosis of oral squamous cell carcinoma patients via L3 skeletal muscle index.
    Lu X; Tian Y; Huang J; Li F; Shao T; Huang G; Lv X
    Oral Dis; 2023 Apr; 29(3):923-932. PubMed ID: 34773352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing skeletal muscle mass based on the cross-sectional area of muscles at the 12th thoracic vertebra level on computed tomography in patients with oral squamous cell carcinoma.
    Matsuyama R; Maeda K; Yamanaka Y; Ishida Y; Kato R; Nonogaki T; Shimizu A; Ueshima J; Kazaoka Y; Hayashi T; Ito K; Furuhashi A; Ono T; Mori N
    Oral Oncol; 2021 Feb; 113():105126. PubMed ID: 33388617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
    Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of
    Song Y; Tian Y; Lu X; Chen G; Lv X
    Med Phys; 2024 Jul; 51(7):4907-4921. PubMed ID: 38252704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
    Swartz JE; Pothen AJ; Wegner I; Smid EJ; Swart KM; de Bree R; Leenen LP; Grolman W
    Oral Oncol; 2016 Nov; 62():28-33. PubMed ID: 27865369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
    Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
    ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prediction model for skeletal muscle evaluation and computed tomography-defined sarcopenia diagnosis in a predominantly overweight cohort of patients with head and neck cancer.
    Vangelov B; Bauer J; Moses D; Smee R
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):321-328. PubMed ID: 35835910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining reference values for low skeletal muscle index at the L3 vertebra level based on computed tomography in healthy adults: A multicentre study.
    Kong M; Geng N; Zhou Y; Lin N; Song W; Xu M; Li S; Piao Y; Han Z; Guo R; Yang C; Luo N; Wang Z; Jiang M; Wang L; Qiu W; Li J; Shi D; Li R; Cheung EC; Chen Y; Duan Z
    Clin Nutr; 2022 Feb; 41(2):396-404. PubMed ID: 34999334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thoracic skeletal muscle index is effective for CT-defined sarcopenia evaluation in patients with head and neck cancer.
    Vangelov B; Smee R; Moses D; Bauer J
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5583-5594. PubMed ID: 37573279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Third Cervical Vertebra Skeletal Muscle Index in Oral Cavity Cancer: A Retrospective Study.
    Chang SW; Hsu CM; Tsai YH; Chang GH; Tsai MS; Huang EI; Tsai YT
    Laryngoscope; 2021 Jul; 131(7):E2257-E2265. PubMed ID: 33433021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of the second thoracic vertebral landmark for skeletal muscle assessment and computed tomography-defined sarcopenia evaluation in patients with head and neck cancer.
    Vangelov B; Bauer J; Moses D; Smee R
    Head Neck; 2023 Apr; 45(4):1006-1016. PubMed ID: 36811256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
    Chang SW; Tsai YH; Hsu CM; Huang EI; Chang GH; Tsai MS; Tsai YT
    PLoS One; 2021; 16(5):e0251455. PubMed ID: 33970954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.
    Zwart AT; van der Hoorn A; van Ooijen PMA; Steenbakkers RJHM; de Bock GH; Halmos GB
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1060-1069. PubMed ID: 31134765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
    Yoon JK; Jang JY; An YS; Lee SJ
    PLoS One; 2021; 16(7):e0254844. PubMed ID: 34280248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of sarcopenia and sarcopenic obesity in patients affected by oral squamous cell carcinoma: A retrospective single-center study.
    Bonavolontà P; Improta G; Dell'Aversana Orabona G; Goglia F; Abbate V; Sorrentino A; Piloni S; Salzano G; Iaconetta G; Califano L
    J Craniomaxillofac Surg; 2023 Jan; 51(1):7-15. PubMed ID: 36739189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis.
    Burian E; Palla B; Callahan N; Pyka T; Wolff C; von Schacky CE; Schmid A; Froelich MF; Rübenthaler J; Makowski MR; Gassert FG
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3870-3877. PubMed ID: 35606526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia and Systemic Inflammation Synergistically Impact Survival in Oral Cavity Cancer.
    Lee J; Liu SH; Dai KY; Huang YM; Li CJ; Chen JC; Leu YS; Liu CJ; Chen YJ
    Laryngoscope; 2021 May; 131(5):E1530-E1538. PubMed ID: 33135827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer.
    Vangelov B; Bauer J; Moses D; Smee R
    Head Neck; 2022 May; 44(5):1047-1056. PubMed ID: 35138008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Skeletal Muscle Changes at Three Vertebral Levels Following Radiotherapy in Patients With Oropharyngeal Carcinoma.
    Vangelov B; Bauer J; Moses D; Smee R
    Nutr Cancer; 2023; 75(2):572-581. PubMed ID: 36308327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive muscle loss is an independent predictor for survival in locally advanced oral cavity cancer: A longitudinal study.
    Lee J; Liu SH; Chen JC; Leu YS; Liu CJ; Chen YJ
    Radiother Oncol; 2021 May; 158():83-89. PubMed ID: 33621588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.